Innoviva Inc (NAS:INVA)
$ 17.65 -0.13 (-0.73%) Market Cap: 1.10 Bil Enterprise Value: 1.30 Bil PE Ratio: 25.58 PB Ratio: 1.65 GF Score: 90/100

Innoviva Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 03:10PM GMT
Release Date Price: $12.61 (-1.56%)
Matthew Harrison
Morgan Stanley & Co. LLC - Analyst

Great morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here. I'm pleased to have Innoviva with us for this session.

Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So with that out of the way, we can get started. So, Pavel, thanks for being here. Thanks for being with us.

Questions & Answers

Matthew Harrison;Pavel Raifeld
Morgan Stanley & Co. LLC - Analyst

And maybe just to kick us off, you have sort of a unique business model compared to a lot of the other companies. So maybe just talk about how you're balancing your royalty portfolio of income with some of the recent acquisitions you've made and how you're thinking about capital deployment more broadly.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot